HLA-DR/HLA-DRA/HLA Mouse Monoclonal Antibody, Clone: [5B13F7], Unconjugated

Catalog Number: BYT-ORB1152388
Article Name: HLA-DR/HLA-DRA/HLA Mouse Monoclonal Antibody, Clone: [5B13F7], Unconjugated
Biozol Catalog Number: BYT-ORB1152388
Supplier Catalog Number: orb1152388
Alternative Catalog Number: BYT-ORB1152388-100
Manufacturer: Biorbyt
Host: Mouse
Category: Antikörper
Application: FC, IHC, WB
Species Reactivity: Human
Immunogen: E.coli-derived human HLA-DR/HLA-DRA recombinant protein (Position: I26-L254).
Conjugation: Unconjugated
Alternative Names: HLA DRA, HLA DRA1, HLA-DR, HLA-DRA, MHC class II antigen DRA
Anti-HLA-DR/HLA-DRA Antibody (monoclonal, 5B13F7). Tested in Flow Cytometry, IHC, WB applications. This antibody reacts with Human.
Clonality: Monoclonal
Concentration: Adding 0.2 ml of distilled water will yield a concentration of 500 µg/ml.
Clone Designation: [5B13F7]
Molecular Weight: 35-37 kDa
UniProt: P01903
Buffer: Each vial contains 4 mg Trehalose, 0.9 mg NaCl and 0.2 mg Na2HPO4.
Form: Lyophilized
Target: HLA class II histocompatibility antigen, DR alpha chain
Application Dilute: Western blot, 0.25-0.5 µg/ml, Human Immunohistochemistry(Paraffin-embedded Section), 2-5 µg/ml, Human Flow Cytometry (Fixed), 1-3 µg/1x10 6 cells, Human
Flow Cytometry analysis of Daudi cells using anti-HLA-DRA antibody. Overlay histogram showing Daudi cells (Blue line). The cells were fixed with 4% paraformaldehyde and blocked with 10% normal goat serum. And then incubated with mouse anti-HLA-DRA Antibody (1 µg/1x10 6 cells) for 30 min at 20C. DyLight488 conjugated goat anti-mouse IgG (5-10 µg/1x10 6 cells) was used as secondary antibody for 30 minutes at 20C. Isotype control antibody (Green line) was mouse IgG (1 µg/1x10 6) used under the same conditions. Unlabelled sample without incubation with primary antibody and secondary antibody (Red line) was used as a blank control.
IHC analysis of HLA-DRA using anti-HLA-DRA antibody. HLA-DRA was detected in a paraffin-embedded section of human bladder epithelial carcinoma tissue. Heat mediated antigen retrieval was performed in EDTA buffer (pH8.0, epitope retrieval solution). The tissue section was blocked with 10% goat serum. The tissue section was then incubated with 2 µg/ml mouse anti-HLA-DRA Antibody overnight at 4C. Peroxidase Conjugated Goat Anti-mouse IgG was used as secondary antibody and incubated for 30 minutes at 37C. The tissue section was developed using HRP Conjugated Mouse IgG Super Vision Assay Kit with DAB as the chromogen.
IHC analysis of HLA-DRA using anti-HLA-DRA antibody. HLA-DRA was detected in a paraffin-embedded section of human colonic adenocarcinoma tissue. Heat mediated antigen retrieval was performed in EDTA buffer (pH8.0, epitope retrieval solution). The tissue section was blocked with 10% goat serum. The tissue section was then incubated with 2 µg/ml mouse anti-HLA-DRA Antibody overnight at 4C. Peroxidase Conjugated Goat Anti-mouse IgG was used as secondary antibody and incubated for 30 minutes at 37C. The tissue section was developed using HRP Conjugated Mouse IgG Super Vision Assay Kit with DAB as the chromogen.
IHC analysis of HLA-DRA using anti-HLA-DRA antibody. HLA-DRA was detected in a paraffin-embedded section of human endometrial cancer tissue. Heat mediated antigen retrieval was performed in EDTA buffer (pH8.0, epitope retrieval solution). The tissue section was blocked with 10% goat serum. The tissue section was then incubated with 2 µg/ml mouse anti-HLA-DRA Antibody overnight at 4C. Peroxidase Conjugated Goat Anti-mouse IgG was used as secondary antibody and incubated for 30 minutes at 37C. The tissue section was developed using HRP Conjugated Mouse IgG Super Vision Assay Kit with DAB as the chromogen.
IHC analysis of HLA-DRA using anti-HLA-DRA antibody. HLA-DRA was detected in a paraffin-embedded section of human hepatocellular carcinoma tissue. Heat mediated antigen retrieval was performed in EDTA buffer (pH8.0, epitope retrieval solution). The tissue section was blocked with 10% goat serum. The tissue section was then incubated with 2 µg/ml mouse anti-HLA-DRA Antibody overnight at 4C. Peroxidase Conjugated Goat Anti-mouse IgG was used as secondary antibody and incubated for 30 minutes at 37C. The tissue section was developed using HRP Conjugated Mouse IgG Super Vision Assay Kit with DAB as the chromogen.
IHC analysis of HLA-DRA using anti-HLA-DRA antibody. HLA-DRA was detected in a paraffin-embedded section of human laryngeal squamous cell carcinoma tissue. Heat mediated antigen retrieval was performed in EDTA buffer (pH8.0, epitope retrieval solution). The tissue section was blocked with 10% goat serum. The tissue section was then incubated with 2 µg/ml mouse anti-HLA-DRA Antibody overnight at 4C. Peroxidase Conjugated Goat Anti-mouse IgG was used as secondary antibody and incubated for 30 minutes at 37C. The tissue section was developed using HRP Conjugated Mouse IgG Super Vision Assay Kit with DAB as the chromogen.
Western blot analysis of HLA-DRA using anti-HLA-DRA antibody. Electrophoresis was performed on a 5-20% SDS-PAGE gel at 70V (Stacking gel) / 90V (Resolving gel) for 2-3 hours. The sample well of each lane was loaded with 30 ug of sample under reducing conditions